Depakote Studies Are Alleging A Connection With Autism

Zoll & Kranz, LLC has been investigating the connection with taking Depakote while pregnant and children being diagnosed with cognitive disorders, such as autism.

Most recently, a Danish study found that mothers who took the drug during pregnancy were five times more likely to give birth to a child with autism.

According to, the study tracked over 665,000 children from 1996 to 2006, of which, 5,500 were diagnosed with autism. Of those who were born with autism, 508 were born to mothers who took valproate drugs.

Keep in mind, last year the US Food and Drug Administration (FDA) issued a safety release saying that pregnant women should not take Depakote for the prevention of migraine headaches. The agency urged usage only as a last resort.

The Danish study comes after an April 2013 article in the Journal of the American Medical Association (JAMA) concluded that the use of the Depakote during pregnancy “was associated with a significantly increased risk of autism in the offspring, even after adjusting for parental psychiatric disease and epilepsy.”

Seeking Counsel- No Cost To You Unless There’s Recovery

As we stated above, our attorneys are involved and investigating the Depakote litigation.  Our priority is you and we are determined to fight on behalf of victims injured by the misleading Big Pharma manufactures.

If your child was harmed because of Depakote use during pregnancy, have your case investigated. For more information about Depakote, please view the video above or call our team toll-free at (888) 841-9623

Zoll & Kranz, LLC – Defective Medical Drug and Device Lawyers